CDKN2A and neoplasm: Several studies have demonstrated associations between abnormal p16 expression, CDKN2A deletion, TP53 mutations, and malignant behavior.[21,22,45] In this case, although no definitive genetic alterations were identified, the pathology consultation suggested a high likelihood of multifocal tumor origin.